网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
磁共振脂肪定量技术分析腹腔内脏脂肪含量与2型糖尿病关系的Meta分析
作者:王金凤1  王海静1  罗琳2  陈强2  原小军2 
单位:1. 内蒙古科技大学 包头医学院, 内蒙古 包头 014010,;
2. 内蒙古科技大学包头医学院第一附属医院 医学影像科, 内蒙古 包头 014010
关键词:2型糖尿病 脂肪 核磁共振 Meta分析 
分类号:R445.3
出版年·卷·期(页码):2024·52·第五期(687-694)
摘要:

目的:基于Meta分析评估磁共振脂肪定量技术在腹腔内脏脂肪含量与2型糖尿病(T2DM)关系中的效能,进而探讨以腹腔内脏脂肪含量预测T2DM发病的可行性。方法:检索PubMed、Embase、The Cochrane Library、知网和万方数据库自1995年1月1日至2023年3月31日关于腹腔内脏脂肪与T2DM关系的中英文文献,依据纳入及排除标准独立筛选文献、提取数据并进行质量评估。最后采用STATA 12.0软件进行统计分析并绘制森林图。采用亚组分析的方法寻找异质性来源,绘制漏斗图以评估是否存在发表偏倚。结果:共纳入16篇文献。共1 814例受试者,其中T2DM组759例,健康对照(HC)组1 055例。T2DM患者的胰腺及肝脏异位脂肪沉积含量高于健康人群,且腹腔内脏脂肪含量亦高于健康人群。T2DM组患者的胰腺脂肪分数(PFF)[加权均数差(WMD)=2.71, 95%CI 2.01~3.41]、肝脏脂肪分数(HFF)(WMD=6.03, 95%CI 4.10~7.95)、腹腔内脏脂肪面积(VFA)(WMD=77.71, 95%CI 39.98~115.43)及皮下脂肪组织面积(SFA)(WMD=27.72, 95%CI 6.76~48.69)均大于HC组,且组间差异有统计学意义(P<0.01)。结论:T2DM患者的腹腔内脏脂肪组织、皮下脂肪组织、肝脏及胰腺脂肪含量明显高于健康人群。磁共振脂肪定量技术为定量测量腹腔内脏脂肪及异位脂肪沉积提供了一种有效的无创性方法指标,在未来用于脂肪定量科研中具有较大的发展前景。

Objective: Based on Meta-analysis, the efficacy of magnetic resonance fat quantification technique in the relationship between abdominal visceral fat content and type 2 diabetes mellitus(T2DM) was evaluated, and the feasibility of predicting the incidence of T2DM with abdominal visceral fat content was discussed. Methods: Chinese and English literatures on the relationship between abdominal visceral fat and T2DM were searched from PubMed, Embase, The Cochrane Library, CNKI and Wanfang Database from January 1, 1995 to March 31, 2023. The literatures were independently screened according to inclusion and exclusion criteria, and the data were extracted and evaluated for quality. Finally, STATA 12.0 software was used for statistical analysis and forest map drawing. Subgroup analysis was used to find the source of heterogeneity, and a funnel plot was drawn to assess the presence of publication bias. Results: A total of 16 literatures were included. A total of 1 814 subjects were enrolled, including 759 in T2DM group and 1 055 in healthy control group. The content of ectopic fat deposition in pancreas and liver of patients with T2DM was higher than that of healthy people, and the content of visceral fat in abdominal cavity was also higher than that of healthy people. In T2DM patients, pancreatic fat fraction(PFF)(WMD=2.71, 95%CI 2.01-3.41), hepatic fat fraction(HFF)(WMD=6.03, 95%CI 4.10-7.95), visceral fat area(VFA)(WMD=77.71, 95%CI 39.98-115.43) and subcutaneous fat area(SFA)(WMD=27.72, 95%CI 6.76-48.69) were higher than those in the healthy control group, and the difference between groups was statistically significant(P<0.01). Conclusion: The contents of visceral fat, subcutaneous fat, liver and pancreas fat in the patients with T2DM were significantly higher than those in the control group. Magnetic resonance fat quantification technology provides an effective non-invasive biological index for the quantitative measurement of visceral fat and ectopic fat deposition in the abdominal cavity, and has great prospects for the development of fat quantification research in the future.

参考文献:

[1] RAMIREZ-ALARCON K,VICTORIANO M,MARDONES L,et al.Phytochemicals as potential epidrugs in type 2 diabetes mellitus[J].Front Endocrinol(Lausanne),2021,1(12):656-978.
[2] OGURTSOVA K,DA ROCHA FERNANDES J D,HUANG Y,et al.IDF diabetes atlas:global estimates for the prevalence of diabetes for 2015 and 2040[J].Diabetes Res Clin Pract,2017,128:4050.
[3] KIM E H,KIM H K,BAE S J,et al.Gender differences of visceral fat area for predicting incident type 2 diabetes in Koreans[J].Diabetes Res Clin Pract,2018,146:93-100.
[4] 安红红,徐静,马迎惠,等.2型糖尿病患者糖脂代谢、血清钙磷、骨代谢与骨密度的相关性研究[J].现代医学,2023,51(3):318-323.
[5] NADARAJAH C,FANANAPAZIR G,CUI E,et al.Association of pancreatic fat content with type II diabetes mellitus[J].Clin Radiol,2020,75(1):51-56.
[6] LI M,ZHENG Q,MILLER J D,et al.Aerobic training reduces pancreatic fat content and improves β-cell function:a randomized controlled trial using IDEAL-IQ magnetic resonance imaging[J].Diabetes Metab Res Rev,2022,38(4):e3516.
[7] 柴军,刘朋,洪旭,等.化学位移MRI对初诊2型糖尿病患者及健康人胰腺脂肪含量的比较研究[J].磁共振成像,2015,6(3):208-212.
[8] HEBER S D,HETTERICH H,LORBEER R,et al.Pancreatic fat content by magnetic resonance imaging in subjects with prediabetes,diabetes,and controls from a general population without cardiovascular disease[J].PLoS One,2017,12(5):e0177154.
[9] 胡竞成,许虹,黄亚楠,等.胰腺脂肪含量与2型糖尿病的相关性[J].中华糖尿病杂志,2017,9(12):770-773.
[10] 黄小燕.采用IDEAL-IQ定量评估糖尿病患者腹部脂肪分布和内脏脂肪沉积[D].温州:温州医科大学,2018.
[11] 李元.胰腺、肝脏异位脂肪沉积IDEAL-IQ定量及MicroRNA-19a-3p与2型糖尿病的相关性研究[D].重庆:重庆医科大学,2018.
[12] STORZ C,ROSPLESZCZ S,LORBEER R,et al.Phenotypic multiorgan involvement of subclinical disease as quantified by magnetic resonance imaging in subjects with prediabetes,diabetes,and normal glucose tolerance[J].Invest Radiol,2018,53(6):357-364.
[13] 曾文彦,孙慧琳,庄娘妥,等.3.0T磁共振IDEAL-IQ技术量化评价2型糖尿病患者胰腺脂肪沉积及铁沉积的价值[J].国际医药卫生导报,2019,25(13):2027-2030.
[14] BORRA R,LAUTAMAKI R,PARKKOLA R,et al.Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus[J].Metabolism,2008,57(10):1445-1451.
[15] WANG M,LUO Y,CAI H,et al.Prediction of type 2 diabetes mellitus using noninvasive MRI quantitation of visceral abdominal adiposity tissue volume[J].Quant Imaging Med Surg,2019,9(6):1076-1086.
[16] SARMA M K,SAUCEDO A,DARWIN C H,et al.Noninvasive assessment of abdominal adipose tissues and quantification of hepatic and pancreatic fat fractions in type 2 diabetes mellitus[J].Magn Reson Imaging,2020,72:95-102.
[17] 段秀苹,雷燕,唐伟.胰腺内脂肪沉积与2型糖尿病相关性的MRI研究进展[J].中国中西医结合影像学杂志,2020,18(5):532-535.
[18] 朱红丽.2型糖尿病异位脂肪沉积与胰岛素抵抗、肌肉功能障碍相关性的磁共振研究[D].昆明:昆明医科大学,2022.
[19] ZHENG Y,YANG S,CHEN X,et al.The correlation between type 2 diabetes and fat fraction in liver and pancreas:a study using MR Dixon technique[J]. Contrast Media Mol Imaging,2022,2022:7073647.
[20] 王骏,郝金华,梁羡和.MRI定量分析肝、胰脂肪含量与糖耐量的相关性[J].国际医药卫生导报,2022,28(19):2740-2743.
[21] YI J,XU F,LI T,et al.Quantitative study of 3T MRI qDixon-WIP applied in pancreatic fat infiltration in patients with type 2 diabetes mellitus[J].Front Endocrinol(Lausanne),2023,14:1140111.
[22] KIEFER L S,FABIAN J,ROSPLESZCZ S,et al.Assessment of the degree of abdominal myosteatosis by magnetic resonance imaging in subjects with diabetes,prediabetes and healthy controls from the general population[J].Eur J Radiol,2018,105:261-268.
[23] FENG Y,YANG X,LI Y,et al.Metabolic score for visceral fat:a novel predictor for the risk of type 2 diabetes mellitus[J].Br J Nutr,2022,128(6):1029-1036.
[24] PAN L,XU Q,LIU J,et al.Dose-response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese[J].Front Endocrinol(Lausanne),2022,13:959860.
[25] TAYLOR R,Al-MRABEH A,SATTAR N.et al.Understanding the mechanisms of reversal of type 2 diabetes[J].Lancet Diabetes Endocrinol,2019,7(9):726-736.
[26] 江伟新,何丹丹,邱山虎,等.强度递增式运动干预对2型糖尿病患者体脂、血糖、血脂控制效果分析[J].现代医学,2023,51(4):535-540.
[27] HUANG S,LIANG Y,ZHONG X,et al.Pancreatic fat fraction in dual-energy computed tomography as a potential quantitative parameter in the detection of type 2 diabetes mellitus[J].Eur J Radiol,2023,159:110668.
[28] YU X,HUANG Y H,FENG Y Z,et al.Well-controlled versus poorly controlled diabetes in patients with obesity:differences in MRI-evaluated pancreatic fat content[J].Quant Imaging Med Surg,2023,13(6):3496-3507.
[29] WEN Y,CHEN C,KONG X,et al.Pancreatic fat infiltration,β-cell function and insulin resistance:a study of the young patients with obesity[J].Diabetes Res Clin Pract,2022,187:109860.
[30] KIM E H,KIM H K,LEE M J,et al.Sex differences of visceral fat area and visceral-to-subcutaneous fat ratio for the risk of incident type 2 diabetes mellitus[J].Diabetes Metab J,2022,46(3):486-498.
[31] 彭晓勇,严俊,黄益龙,等.3D-IDEAL-IQ定量评估2型糖尿病患者肝脏和胰腺脂肪浸润及其与胰岛素抵抗的相关性[J].磁共振成像,2023,14(4):89-94.
[32] WAGNER R,ECKSTEIN S S,YAMAZAKI H,et al.Metabolic implications of pancreatic fat accumulation[J].Nat Rev Endocrinol,2022,18(1):43-54.
[33] YAMAZAKI H,TAUCHI S,MACHANN J,et al.Fat distribution patterns and future type 2 diabetes[J].Diabetes,2022,71(9):1937-1945.
[34] DEMIR S,NAWROTH P P,HERZIG S,et al.Emerging targets in type 2 diabetes and diabetic complications[J].Adv Sci(Weinh),2021,8(18):e2100275.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 822442 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

本系统由北京博渊星辰网络科技有限公司设计开发 技术支持电话:010-63361626

苏ICP备09058541